Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness

Record Fiscal Year Net Revenue of $915 Million, Record Gross Profit, Consistent Adjusted Gross Margin3 and Record Adjusted EBITDA5 Highlights the Strength of Tilray’s Scaled Businesses and Profitable Growth Strategy International Medical Cannabis Revenue Increased 34% for the Fiscal Year, Reinforcing Tilray’s Leadership Across Europe and Expanding Patient Access at Scale BrewDog Acquisition Ignited the Global […]